Literature DB >> 33180269

Differential Expression of Cytokine-Coding Genes among Migraine Patients with and without Aura and Normal Subjects.

Mohammad Taheri1, Fwad Nicknafs2, Omid Hesami3, Abdolreza Javadi4, Shahram Arsang-Jang5, Arezou Sayad6, Soudeh Ghafouri-Fard7.   

Abstract

Migraine is a prevalent disorder in humans and represents one of the top 10 causes of years lived with disability. Several genetic and environmental factors are involved in the pathobiology of migraine. A number of studies have underscored the role of dysregulated immune reactions. We compared the expression levels IL-2, IL-4, CXCL8, IL-17, IFN-γ, TGF-β and TNF-α cytokines in blood specimens of patients with migraine and those of healthy persons to identify any possible dysregulation in their expression and to propose mechanisms for this disorder. Expression of INF-γ was suggestively higher in migraine cases than in healthy individuals (posterior beta = 0.35, adjusted P value = 0.017). In addition, expression of this cytokine was lower in female subjects than in male subjects (posterior beta = -0.712, adjusted P value = 0.012). Expression of IL-4, TGF-β and TNF-α was also higher in cases compared with controls (posterior beta = 1.34, adjusted P value = 0.04; posterior beta = 0.849, adjusted P value = 0.036; posterior beta = 0.451, adjusted P value = 0.042, respectively). On the other hand, CXCL8 expression was lower in migraine cases than in controls (posterior beta = -0.78, adjusted P value = 0.039). Expression levels of IL-1B, IL-17 and IL-2 were not meaningfully different between cases and controls. The current study highlights the dysregulation of cytokine-coding genes in the blood of patients with migraine.

Entities:  

Keywords:  Aura; Cytokine; Migraine

Year:  2020        PMID: 33180269     DOI: 10.1007/s12031-020-01745-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  2 in total

Review 1.  An overview on immune system and migraine.

Authors:  P P Bruno; F Carpino; G Carpino; A Zicari
Journal:  Eur Rev Med Pharmacol Sci       Date:  2007 Jul-Aug       Impact factor: 3.507

  2 in total
  5 in total

Review 1.  Dural Immune Cells, CGRP, and Migraine.

Authors:  Louis K Balcziak; Andrew F Russo
Journal:  Front Neurol       Date:  2022-03-31       Impact factor: 4.086

2.  Evaluation of simple antioxidant blood parameters in patients with migraine.

Authors:  Zhenzhen Yang; Pengfei Xu; Chaofan Geng; Hongju Zhang
Journal:  Front Neurol       Date:  2022-07-26       Impact factor: 4.086

3.  Clinical effect of flunarizine combined with duloxetine in the treatment of chronic migraine comorbidity of depression and anxiety disorder.

Authors:  Junliang Zhu; Jianhuang Chen; Kaixue Zhang
Journal:  Brain Behav       Date:  2022-07-05       Impact factor: 3.405

Review 4.  Immunologic aspects of migraine: A review of literature.

Authors:  Mehrnaz Salahi; Sina Parsa; Delaram Nourmohammadi; Zahra Razmkhah; Omid Salimi; Mohammadreza Rahmani; Saeid Zivary; Monireh Askarzadeh; Mohammad Amin Tapak; Ali Vaezi; Hamidreza Sadeghsalehi; Shirin Yaghoobpoor; Mehran Mottahedi; Setareh Garousi; Niloofar Deravi
Journal:  Front Neurol       Date:  2022-09-28       Impact factor: 4.086

5.  Association of Body Mass Index, Blood Pressure, and Interictal Serum Levels of Cytokines in Migraine with and without Aura.

Authors:  Aelita Plinta; Peteris Tretjakovs; Simons Svirskis; Inara Logina; Gita Gersone; Antra Jurka; Indra Mikelsone; Leons Blumfelds; Vitolds Mackevics; Guntis Bahs
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.